NOTIFICATION OF TRADE AMONG PRIMARY INSIDERS

On 15 January 2010 mandatory notifications of trade among primary

insiders of DiaGenic ASA took place. The primary insiders have settled

the Total Return equity Swap (TRS) agreements with exposure for 835,000

shares in DiaGenic and subsequently entered into new TRS agreements for

835,000 shares. Net exposure among the insiders is unchanged by these

transactions. The transactions are described in more detail below.

Håkon Sæterøy, Executive Chairman of the Board of DiaGenic ASA, has

through Investor Corporate AS, which is controlled by Sæterøy, settled a

Total Return equity Swap agreement (TRS) with exposure of 135,000

underlying shares at a price of NOK 3.24 per share and with expiry date

set to 26 January 2010. Subsequently Sæterøy entered into a new TRS

agreement with exposure for 135,000 underlying shares and with expiry

date set to 25 March 2010, and the TRS price is set to NOK 3.27 per

share. After these transactions, Sæterøy directly and indirectly owns a

total of 1,396,478 shares, 155,000 warrants (as resolved by the general

meeting on 18 December 2009), in addition to the TRS agreement with

exposure for 135,000 shares.

Director and board member Praveen Sharma has settled a Total Return

equity Swap agreement (TRS) with exposure of 700,000 underlying shares

at a price of NOK 3.08 per share and with expiry date set to 16 January

2010. Subsequently Sharma entered into a new TRS agreement with exposure

for 700,000 underlying shares and with expiry date set to 15 March 2010,

and the TRS price is set to NOK 3.11 per share. After the transactions

Sharma owns a total of 2,295,000 shares in DiaGenic in addition to the

TRS agreement with exposure for 700,000 shares.

This information is subject of the disclosure requirements acc. to §5-12

vphl (Norwegian Securities Trading Act).

Contact:

MD PhD Erik Christensen, Managing Director

Telephone: +47 95939918

AI Terminal